ESC 2021: Lexicon aims to make its heart failure case with sotagliflozin, a dual SGLT1 and SGLT2 inhibitor August 20, 2021 Auto Bot News 0 ESC 2021: Lexicon aims to make its heart failure case with sotagliflozin, a dual SGLT1 and SGLT2 inhibitor esagonowsky Fri, 08/20/2021 – 14:18
